The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Chitika, Inc., In the Matter of
1106003 Informal Interpretation
1106003 Informal Interpretation
1106005 Informal Interpretation
1106005 Informal Interpretation
Lookout Services, Inc., In the Matter of
Ceridian Corporation, In the Matter of
Prepared Statement of the Federal Trade Commission On Data Security
20110955: The Resolute Fund II, L.P.; Odyssey Investment Partners Fund III, L.P.
Legacy Learning Systems, Inc., et al., In the Matter of
20110917: Roger S. Penske; Donald J. Crevier
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
Best Priced Brands, LLC, et al.
Grifiols, S.A. and Talecris Biotherapeutics Holdings Corp.; Analysis of Agreement Containing Consent Orders to Aid Public Comment: Proposed Consent Agreement
Hikma Pharmaceuticals PLC, In the Matter of (Baxter)
The Commission required Hikma Pharmaceuticals PLC (Hikma) to divest two generic injectable pharmaceuticals – phenytoin and promethazine – as part of a settlement allowing it to acquire certain assets from Baxter Healthcare Corporation, Inc. (Baxter). Hikma proposes to acquire Baxter’s entire generic injectable pharmaceutical business for $111.5 million, including Baxter’s Cherry Hill, New Jersey, manufacturing facility and a warehouse and distribution center in Memphis, Tennessee. Phenytoin is an anti-convulsant drug used to control and prevent seizures during or after surgery and Promethazine is used to prevent some types of allergies or allergic reactions, to prevent or control motion sickness, nausea, vomiting, and dizziness, and to help patients go to sleep and control their pain or anxiety before or after surgery.